Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression

Inosine pranobex (IP) is a synthetic immunomodulating compound, indicated for use in the treatment of human papillomavirus‐associated warts and subacute sclerosing panencephalitis. Previous studies demonstrate that the immunomodulatory activity of IP is characterized by enhanced lymphocyte prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Michael T., Lin, Da, Soga, Tomoyoshi, Adam, Julie, O'Callaghan, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Immunomodulation and immune therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972573/
https://www.ncbi.nlm.nih.gov/pubmed/31434164
http://dx.doi.org/10.1002/eji.201847948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972573/
https://www.ncbi.nlm.nih.gov/pubmed/31434164
http://dx.doi.org/10.1002/eji.201847948

Ejemplares similares